We are Epilepsy Society. The UK’s only charity transforming the lives of people with epilepsy through world-leading research, advocacy and care.
The Chalfont Centre and our Gowers unit lead the way in the most advanced techniques for the diagnosis and treatment of epilepsy.
We are the leading charity care provider, where people love to work and live. Our wide range of care is tailored to the needs of each individual, and our professional staff are committed to maximising the life potential of everyone within our care homes.
Our campaigns team lobby government and decision-makers on the issues that matter to people with epilepsy. From safer medicines for pregnant women to the dangers of online trolling, and from medicines supply to public transport access, we raise awareness of the daily challenges facing people with epilepsy.
New research has revealed that slow brain waves, which usually occur during sleep, could also offer protection against increased brain excitability in people with epilepsy.
After recently seeing some big successes with people putting up our Calm, Cushion, Call posters where they live, we’re asking even more of you to spread the word about our seizure first aid advice at local level.
Additional new restrictions are to be introduced for the prescribing of valproate from 31 January 2024. Read about the changes
We recently took our external training onto the international stage for the first time, delivering an online course for a group of nurses based at a hospital in Hong Kong.
A research team based at Oxford University is looking for mothers with epilepsy who have given birth in the last five years to join an advisory group exploring postnatal care and support.
The Government has set out plans for new welfare reforms, which it says will help more people with disabilities and health conditions such as epilepsy to benefit from flexible working, including working from home.
The ultimate goals of our current research are to spearhead personalised treatment and to incorporate genomic diagnosis into the NHS for people with epilepsy.
Therapeutic drug monitoring (TDM) is an area of clinical chemistry that specialises in measuring medication levels (concentrations) in patients, usually through blood samples but also through saliva samples.
Read how we are working to understand the genetic architecture of each individual person's epilepsy through our world leading genomics research programme.
You can call our helpline on 01494 601 400.
Monday and Wednesday - 9am to 7.30pm
Tuesday, Thursday, and Friday - 9am to 4pm
Saturday - 9am to 12.30pm
You can also reach us by email